申请人:Boehringer Ingelheim GmbH
公开号:US04213985A1
公开(公告)日:1980-07-22
Novel 5,11-dihydro-6H-pyrido-[2,3-b][1,4]-benzodiazepine-6-ones of the formula ##STR1## wherein R.sub.1 is selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms, straight and branched chain, mono and poly unsaturated aliphatic hydrocarbon of 3 to 20 carbon atoms, phenyl alkyl of 1 to 4 alkyl carbon atoms and cinnamyl, R.sub.2 is selected from the group consisting of hydrogen, methyl and ethyl and A is straight or branched chain alkylene of 2 to 5 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having ulcer inhibiting and secretion inhibiting activity and a novel process for their preparation.
化学式为 ##STR1## 的新型5,11-二氢-6H-吡啶[2,3-b][1,4]-苯二氮平-6-酮,其中R.sub.1选自氢、1至6个碳原子的烷基、直链和支链、3至20个碳原子的单烯和多烯不饱和脂肪烃、1至4个烷基碳原子的苯基烷基和肉桂基,R.sub.2选自氢、甲基和乙基,A为直链或支链的2至5个碳原子的烷基,以及其非毒性、药学上可接受的酸盐,具有抑制溃疡和分泌的活性,以及其制备的新方法。